National Notifiable Diseases Surveillance System, 1 July to 30 September 2015

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period1 July to 30 September 2015

Page last updated: 24 December 2015

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 122,283 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 July to 30 September 2015 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infection with Shiga toxin/verotoxin-producing Escherichia coli.

NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
All jurisdictions
Hepatitis B (newly acquired)
All jurisdictions
Hepatitis B (unspecified)
All jurisdictions
Hepatitis C (newly acquired)
All jurisdictions except Queensland
Hepatitis C (unspecified)
All jurisdictions
Hepatitis D
All jurisdictions
Gastrointestinal diseases
Botulism
All jurisdictions
Campylobacteriosis
All jurisdictions except New South Wales
Cryptosporidiosis
All jurisdictions
Haemolytic uraemic syndrome
All jurisdictions
Hepatitis A
All jurisdictions
Hepatitis E
All jurisdictions
Listeriosis
All jurisdictions
STEC, VTEC*
All jurisdictions
Salmonellosis
All jurisdictions
Shigellosis
All jurisdictions
Typhoid fever
All jurisdictions
Quarantinable diseases
Cholera
All jurisdictions
Highly pathogenic avian influenza (human)
All jurisdictions
Plague
All jurisdictions
Rabies
All jurisdictions
Severe acute respiratory syndrome
All jurisdictions
Smallpox
All jurisdictions
Viral haemorrhagic fever
All jurisdictions
Yellow fever
All jurisdictions
Sexually transmissible infections
Chlamydia
All jurisdictions
Donovanosis
All jurisdictions
Gonococcal infection
All jurisdictions
Syphilis - congenital
All jurisdictions
Syphilis < 2 years duration
All jurisdictions
Syphilis > 2 years or unspecified duration
All jurisdictions
Vaccine preventable diseases
Diphtheria
All jurisdictions
Haemophilus influenzae type b
All jurisdictions
Influenza (laboratory confirmed)
All jurisdictions
Measles
All jurisdictions
Mumps
All jurisdictions
Pertussis
All jurisdictions
Pneumococcal disease – invasive
All jurisdictions
Poliovirus infection
All jurisdictions
Rubella
All jurisdictions
Rubella - congenital
All jurisdictions
Tetanus
All jurisdictions
Varicella zoster (chickenpox)
All jurisdictions except New South Wales
Varicella zoster (shingles)
All jurisdictions except New South Wales
Varicella zoster (unspecified)
All jurisdictions except New South Wales
Vectorborne diseases
Barmah Forest virus infection
All jurisdictions
Chikungunya virus infection
All jurisdictions
Dengue virus infection
All jurisdictions
Flavivirus infection (unspecified)
All jurisdictions
Japanese encephalitis virus infection
All jurisdictions
Kunjin virus infection
All jurisdictions
Malaria
All jurisdictions
Murray Valley encephalitis virus infection
All jurisdictions
Ross River virus infection
All jurisdictions
Zoonoses
Anthrax
All jurisdictions
Australian bat lyssavirus infection
All jurisdictions
Brucellosis
All jurisdictions
Leptospirosis
All jurisdictions
Lyssavirus infection (NEC)
All jurisdictions
Ornithosis
All jurisdictions
Q fever
All jurisdictions
Tularaemia
All jurisdictions
Other bacterial infections
Legionellosis
All jurisdictions
Leprosy
All jurisdictions
Meningococcal infection – invasive
All jurisdictions
Tuberculosis
All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 July to 30 September 2015, by date of diagnosis*
  State or territory Total 3rd quarter 2015 Total 2nd quarter 2015 Total 3rd quarter 2014 Last 5 years mean 3rd quarter Ratio Year to date 2015 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas. Vic. WA

* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis   unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.

Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)
0
4
1
15
2
0
6
6
34
39
37
47.2
0.7
113
148.2
Hepatitis B (unspecified)
21
712
50
314
81
12
325
159
1,674
1,548
1,690
1,751.4
1.0
4,799
5,002.2
Hepatitis C (newly acquired)
4
6
1
0
6
8
35
57
117
108
106
99.4
1.2
328
323.0
Hepatitis C (unspecified)
45
894
52
627
104
63
201
213
2,199
2,500
2,645
2,682.6
0.8
7,227
7,710.0
Hepatitis D
0
1
0
8
3
0
0
0
12
12
14
12.6
1.0
34
36.0
Gastrointestinal diseases
Botulism
0
0
0
0
0
0
0
0
0
1
0
0.4
0.0
2
1.4
Campylobacteriosis
159
NN
99
1,806
478
242
270
654
3,708
4,087
4,761
4,083.8
0.9
13,229
12,225.0
Cryptosporidiosis
5
88
8
141
48
7
159
21
477
988
419
342.8
1.4
2,945
2,097.4
Haemolytic uraemic syndrome
0
3
0
2
0
0
0
1
6
4
4
3.2
1.9
14
11.8
Hepatitis A
1
11
2
4
1
0
5
4
28
28
51
45.6
0.6
144
154.8
Hepatitis E
0
6
0
0
0
0
1
0
7
4
10
6.2
1.1
21
30.6
Listeriosis
0
3
0
2
1
0
4
4
14
19
18
13.6
1.0
49
57.6
STEC, VTEC§
0
3
0
6
5
0
5
0
19
35
22
32.6
0.6
83
89.0
Salmonellosis
41
581
93
671
220
35
727
306
2,674
4,186
2,743
2,222.6
1.2
13,272
9,670.0
Shigellosis
2
42
20
41
15
2
132
17
271
263
250
140.8
1.9
868
466.8
Typhoid fever
0
6
0
5
2
1
3
2
19
29
22
19.0
1.0
91
95.4
Quarantinable diseases
Cholera
0
0
0
0
0
0
0
0
0
1
0
1.0
0.0
1
3.4
Highly pathogenic avian influenza (human)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.5
Sexually transmissible infections
Chlamydia||,¶
318 5,375 683 5,254 1,285 395 0 2,747 16,057 16,363 20,752 20,076.6 0.8 54,591 61,894.8
Donovanosis
0 0 0 0 0 0 0 0 0 0 0 0.4 0.0 0 0.6
Gonococcal infection
28 1,434 406 691 134 12 82 612 3,399 4,593 3,647 3,183.2 1.1 12,621 10,038.6
Syphilis – congenital
0 0 0 2 0 0 0 0 2 2 4 2.2 0.9 4 3.8
Syphilis < 2 years duration
6 180 64 182 17 4 196 52 701 637 541 399.0 1.8 1,939 1,163.6
Syphilis > 2 years or unspecified duration‡,¶
1 164 5 61 26 2 219 21 499 490 479 396.0 1.3 1,474 1,157.2
Vaccine preventable diseases
Diphtheria
0
0
0
1
0
0
0
0
1
0
1
0.4
2.5
2
1.4
Haemophilus influenzae type b
0
2
0
3
0
0
2
1
8
4
6
6.0
1.3
14
14.2
Influenza (laboratory confirmed)
920
25,650
348
22,330
11,725
1,152
12,639
3,650
78,414
9,788
53,023
25,726.8
3.0
92,685
31,708.8
Measles
0
0
0
11
0
0
7
1
19
19
57
58.8
0.3
65
149.4
Mumps
3
12
5
8
4
0
10
150
192
101
47
40.2
4.8
352
132.6
Pertussis
129
3,211
13
293
317
13
1,131
489
5,596
4,219
3,138
6,086.4
0.9
13,839
16,698.0
Pneumococcal disease – invasive
9
205
18
98
44
16
126
71
587
402
588
643.0
0.9
1,176
1,326.8
Poliovirus infection
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
0
1
0
1
0
0
0
2
4
5
3
10.0
0.4
14
30.4
Rubella – congenital
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.4
Tetanus
0
0
0
0
0
0
0
0
0
1
0
0.6
0.0
1
2.6
Varicella zoster (chickenpox)
16
NN
29
126
101
19
9
150
450
534
545
596.6
0.8
1,510
1,419.8
Varicella zoster (shingles)
57
NN
83
9
498
56
9
346
1,058
1,564
1,323
1,051.8
1.0
4,207
3,232.2
Varicella zoster (unspecified)
40
NN
3
1,672
62
39
5
343
2,164
3,251
3,035
2,516.8
0.9
8,462
7,185.8
Vectorborne diseases
Barmah Forest virus infection
0
23
5
44
0
1
1
10
84
194
89
335.4
0.3
540
1,613.4
Chikungunya virus infection
0
7
1
0
0
0
3
2
13
27
17
14.6
0.9
95
50.2
Dengue virus infection
6
67
5
33
12
3
66
64
256
426
282
286.4
0.9
1,425
1,129.2
Flavivirus infection (unspecified)
0
0
0
0
0
0
0
1
1
2
2
3.8
0.3
7
11.8
Japanese encephalitis virus infection
0
0
0
0
0
0
0
0
0
0
1
0.6
0.0
2
1.2
Kunjin virus infection
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.8
Malaria
2
11
6
10
2
0
17
11
59
47
84
99.4
0.6
169
289.0
Murray Valley encephalitis virus infection
0
0
0
0
0
0
0
0
0
1
0
0.0
0.0
2
3.2
Ross River virus infection
0
179
67
398
11
0
32
129
816
2,066
879
595.4
1.4
8,543
3,920.0
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Australian bat lyssavirus infection
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Brucellosis
0
1
1
2
0
0
0
0
4
7
5
6.6
0.6
15
18.0
Leptospirosis
0
4
0
11
0
0
1
1
17
18
19
20.2
0.8
60
107.2
Lyssavirus infection (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
0
0
0
0
0
3
0
3
2
10
13.0
0.2
7
38.4
Q fever
0
75
0
59
3
0
12
4
153
141
118
98.0
1.6
450
303.6
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.3
Other bacterial infections
Legionellosis
0
23
1
20
8
2
14
22
90
103
109
103.0
0.9
285
289.6
Leprosy
0
0
1
1
0
0
1
2
5
3
0
2.4
2.1
9
7.4
Meningococcal infection – invasive**
1
16
0
9
14
1
17
8
66
49
57
67.8
1.0
141
157.2
Tuberculosis
4
111
2
47
22
2
93
25
306
309
353
356.6
0.9
894
964.8
Total
1,818
39,111
2,072
35,018
15,251
2,087
16,568
10,358
122,283
59,220
102,006
248,820

Top of page

Table 3: Notification rates of diseases, 1 July to 30 September 2015, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust.
ACT NSW NT Qld SA Tas. Vic. WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

** The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.

Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)
0.0
0.2
1.6
1.3
0.5
0.0
0.4
0.9
0.6
Hepatitis B (unspecified)§
21.8
37.9
81.8
26.6
19.2
9.3
22.3
24.8
28.5
Hepatitis C (newly acquired)
4.2
0.3
1.6
0.0
1.4
6.2
2.4
8.9
2.0
Hepatitis C (unspecified)§
46.7
47.6
85.0
53.1
24.7
49.0
13.8
33.2
37.5
Hepatitis D
0.0
0.1
0.0
0.7
0.7
0.0
0.0
0.0
0.2
Gastrointestinal diseases
Botulism
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis
165.0
NN
161.9
153.0
113.4
188.1
18.5
102.0
92.9
Cryptosporidiosis
5.2
4.7
13.1
11.9
11.4
5.4
10.9
3.3
8.1
Haemolytic uraemic syndrome
0.0
0.2
0.0
0.2
0.0
0.0
0.0
0.2
0.1
Hepatitis A
1.0
0.6
3.3
0.3
0.2
0.0
0.3
0.6
0.5
Hepatitis E
0.0
0.3
0.0
0.0
0.0
0.0
0.1
0.0
0.1
Listeriosis
0.0
0.2
0.0
0.2
0.2
0.0
0.3
0.6
0.2
STEC,VTEC||
0.0
0.2
0.0
0.5
1.2
0.0
0.3
0.0
0.3
Salmonellosis
42.5
30.9
152.1
56.8
52.2
27.2
49.8
47.7
45.6
Shigellosis
2.1
2.2
32.7
3.5
3.6
1.6
9.0
2.7
4.6
Typhoid fever
0.0
0.3
0.0
0.4
0.5
0.8
0.2
0.3
0.3
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Human pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydia¶,**
330.0
286.1
1,116.9
445.1
305.0
307.0
0.0
428.3
273.6
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection**
29.1
76.3
663.9
58.5
31.8
9.3
5.6
95.4
57.9
Syphilis – congenital
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0.0
Syphilis < 2 years duration**
6.2
9.6
104.7
15.4
4.0
3.1
13.4
8.1
11.9
Syphilis > 2 years or unspecified duration§,**
1.0
8.7
8.2
5.2
6.2
1.6
15.0
3.3
8.5
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.1
0.0
0.3
0.0
0.0
0.1
0.2
0.1
Influenza (laboratory confirmed)
954.6
1,365.1
569.1
1,891.8
2,782.7
895.3
865.8
569.1
1,336.1
Measles
0.0
0.0
0.0
0.9
0.0
0.0
0.5
0.2
0.3
Mumps
3.1
0.6
8.2
0.7
0.9
0.0
0.7
23.4
3.3
Pertussis
133.9
170.9
21.3
24.8
75.2
10.1
77.5
76.2
95.4
Pneumococcal disease – invasive
9.3
10.9
29.4
8.3
10.4
12.4
8.6
11.1
10.0
Poliovirus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.3
0.1
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
16.6
NN
47.4
10.7
24.0
14.8
0.6
23.4
11.3
Varicella zoster (shingles)
59.1
NN
135.7
0.8
118.2
43.5
0.6
53.9
26.5
Varicella zoster (unspecified)
41.5
NN
4.9
141.7
14.7
30.3
0.3
53.5
54.2
Vectorborne diseases
Barmah Forest virus infection
0.0
1.2
8.2
3.7
0.0
0.8
0.1
1.6
1.4
Chikungunya virus infection
0.0
0.4
1.6
0.0
0.0
0.0
0.2
0.3
0.2
Dengue virus infection
6.2
3.6
8.2
2.8
2.8
2.3
4.5
10.0
4.4
Flavivirus infection (unspecified)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
Japanese encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
2.1
0.6
9.8
0.8
0.5
0.0
1.2
1.7
1.0
Murray Valley encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
0.0
9.5
109.6
33.7
2.6
0.0
2.2
20.1
13.9
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.1
1.6
0.2
0.0
0.0
0.0
0.0
0.1
Leptospirosis
0.0
0.2
0.0
0.9
0.0
0.0
0.1
0.2
0.3
Lyssavirus infection (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.1
Q fever
0.0
4.0
0.0
5.0
0.7
0.0
0.8
0.6
2.6
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
0.0
1.2
1.6
1.7
1.9
1.6
1.0
3.4
1.5
Leprosy
0.0
0.0
1.6
0.1
0.0
0.0
0.1
0.3
0.1
Meningococcal infection – invasive††
1.0
0.9
0.0
0.8
3.3
0.8
1.2
1.2
1.1
Tuberculosis
4.2
5.9
3.3
4.0
5.2
1.6
6.4
3.9
5.2

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now